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The embryonic response to ionizing radiations is poorly 
characterized. Although teratology was frequently ob-
served after in utero exposure, little is known about the 
mechanisms involved. At early embryogenesis, a signifi-
cant contribution to the morphogenetic program is given 
by the primitive endoderm (PrE) and its derivatives, vis-
ceral and parietal endoderm (VE, PE). These extra-
embryonic membranes originate within the post-
implantation blastocyst and were shown to directly inter-
act with the epiblast, driving the formation of main ven-
tral structures such as head and heart [1]. Stem cells rep-
resenting the extra-embryonic endoderm (XEN) lineages 
can be generated in vitro, preserving the morphological 
and functional identity of the in vivo counterparts. As 
observed in recent studies, these cells retain the expres-
sion of the typical endoderm markers [2] and still main-
tain their morphogenetic role [3].   
The in vitro XEN derivation would represent a simplified 
tool to assess the early morphogenetic events offering, 
therefore, the opportunity to investigate the physiologic 
response to ionizing radiation. 
 
Here, extra-embryonic endoderm stem cells were generat-
ed from mouse embryonic stem cells (mESCs) in an at-
tempt to establish a stable population. Pluripotent D3 
mESCs were cultured for a prolonged time in XEN medi-
um, and activin A and retinoic acid were employed to 
induce the endoderm specification according to Niakan et 
al. [4]. The samples were treated until the XEN morphol-
ogy was detected in culture. Quantitative PCR analyses 
were executed to verify XEN differentiation. The expres-
sion profile of differentiated cells was evaluated after 30 
days of culture and the production of pluripotency (Sox 2, 
Oct 4) and endoderm (Sox 7, Sox 17, Gata 6) markers 
was quantified and compared to the ones detected in the 
undifferentiated samples.  
As shown in Figure 1, the pluripotent mESCs retain a 
higher expression of the transcription factors Sox 2 and 
Oct 4 and a significantly lower production of the endo-
derm factors can be detected at this stage.  
 
 
 
 
 
  
 
 
 
 
 
 
 
Fig.1 Gene expression profile of mESCs and in vitro derived XEN 
cells. An increased expression of the endodermic markers Gata 6, Sox 7 
and Sox 17 can be detected in the treated cells after 30 days in XEN 
medium. The quantitative amount of Oct 4 and Sox 2 transcripts signifi-
cantly decreases during the differentiation. 
 
In the treated cells, however, the expression of Sox 7, Sox 
17 and Gata 6 is increased, as expected for XEN lines.  
As already observed in previous studies, a basal produc-
tion of the pluripotency markers is preserved in the XEN 
population, confirming their stem cells identity (fig.1, 
[4]). Although XEN differentiation was successful, the 
obtained cell population was still highly heterogeneous, 
which caused a delayed appearance of XEN colonies im-
peding the establishment of stable cell lines. 
Further improvements are needed to guarantee the selec-
tion of the desired cell type and its maintenance and prop-
agation. 
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